JESSICA HANEHAN: Open Payments
NPI 1932837325 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 34 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $265 |
| ABBVIE INC. | 6 | $136 |
| Actelion Pharmaceuticals US, Inc. | 1 | $118 |
| Verona Pharma, Inc. | 1 | $104 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Lilly USA, LLC | 2 | $45 |
| Astellas Pharma US Inc | 2 | $40 |
| Renalytix AI, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
Products named: Wegovy, UPTRAVI, Ohtuvayre, VRAYLAR, AIRSUPRA, JARDIANCE, TRELEGY ELLIPTA, Veozah.
Industry payments across NY — which companies pay providers there.
